This inventor holds 3 USPTO granted patents and 2 published patent applications. Top assignees: G.d. Searle & Company, Monsanto Company, Novo Capsid Technologies LLC. Active years: 1994-2026.
Company Filing History:
1 out of 1,323 
1 out of 3,289 
1 out of 1 Years Active: 1994-2026
Title: Verne A. Luckow: Innovator in Vaccine Development and Recombinant Virus Production
Introduction
Verne A. Luckow is a notable inventor based in Chesterfield, MO (US). He has made significant contributions to the fields of virology and vaccine development. With a total of 3 patents, his work has had a considerable impact on medical science.
Latest Patents
One of his latest patents is for an assembly-deficient herpesvirus vaccine. This innovative vaccine comprises an assembly-deficient herpesvirus that can infect and replicate DNA in susceptible mammal cells. However, it is defective in capsid assembly and the formation of mature virion particles. The assembly-deficient herpesvirus is avirulent and capable of generating a protective immune response in vaccinated mammals. Another significant patent is a method for producing recombinant eukaryotic viruses in bacteria. This method describes a novel baculovirus shuttle vector that contains a low-copy-number bacterial replicon, a selectable drug resistance marker, and a preferred attachment site for a site-specific bacterial transposon. This shuttle vector can replicate in E. coli as a plasmid and is stably inherited after many generations of growth. Bacmid DNA isolated from E. coli is infectious when introduced into susceptible lepidopteran insect cells.
Career Highlights
Throughout his career, Verne A. Luckow has worked with prominent companies such as Monsanto Company and G.D. Searle & Company. His experience in these organizations has contributed to his expertise in the field of biotechnology and virology.
Collaborations
Verne has collaborated with notable coworkers, including Stephen C. Lee and Mark S. Leusch. These collaborations have further enhanced his research and development efforts in the field.
Conclusion
Verne A. Luckow's innovative work in vaccine development and recombinant virus production showcases his significant contributions to science and medicine. His patents reflect a commitment to advancing healthcare through innovative solutions.